Publications Database

Stigler K. A. et al. (2004)

A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 49-56

Read Abstract (New Window)

Stigler K. A. et al. (2009)

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Journal of Child and Adolescent Psychopharmacology

19(3), pp. 265-274

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. et al. (2009)

Autism and immune factors: A comprehensive review.

Research in Autism Spectrum Disorders

pp. 840-860

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2004)

Case report: aripiprazole for maladaptive behavior in pervasive developmental disorder.

Journal of Child and Adolescent Psychopharmacology

14(3), pp. 455-463

Read Abstract (New Window)

Stigler K. A. et al. (2010)

Paliperidone for irritability in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

pp. 75-78

Read Extract (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Stigler K. A. (2014)

Psychopharmacologic management of serious behavioral disturbance in ASD.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 73-82.

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2006)

Ramelteon for insomnia in two youths with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 631-636

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2002)

Recent advances in the pharmacotherapy of autism.

Expert Review of Neurotherapeutics

2(4), pp. 499-510

Read Abstract (New Window)

Stigler K. A. et al. (2004)

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Pediatric Drugs

6(1), pp. 33-44

Read Abstract (New Window)

Wink L. K. et al. (2010)

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Expert Opinion on Emerging Drugs

September, 15(3), pp. 481-494

Read Abstract (New Window)